Femke Molema

540 total citations
7 papers, 156 citations indexed

About

Femke Molema is a scholar working on Clinical Biochemistry, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Femke Molema has authored 7 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Biochemistry, 3 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Femke Molema's work include Metabolism and Genetic Disorders (6 papers), Folate and B Vitamins Research (3 papers) and Mitochondrial Function and Pathology (2 papers). Femke Molema is often cited by papers focused on Metabolism and Genetic Disorders (6 papers), Folate and B Vitamins Research (3 papers) and Mitochondrial Function and Pathology (2 papers). Femke Molema collaborates with scholars based in Netherlands, Germany and Croatia. Femke Molema's co-authors include Monique Williams, Stefan Kölker, Janneke G. Langendonk, Friederike Hörster, Barbara de Koning, Carlo Dionisi‐Vici, Trine Tangeraas, Anke Schumann, W. Onkenhout and Ans T. van der Ploeg and has published in prestigious journals such as Clinical Nutrition, Journal of Inherited Metabolic Disease and JIMD Reports.

In The Last Decade

Femke Molema

7 papers receiving 154 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Femke Molema Netherlands 7 136 65 55 38 25 7 156
Anil Jalan India 6 80 0.6× 58 0.9× 23 0.4× 24 0.6× 12 0.5× 17 137
Jennifer Seminara United States 4 159 1.2× 82 1.3× 32 0.6× 58 1.5× 44 1.8× 5 211
Mick Henderson United Kingdom 6 114 0.8× 100 1.5× 21 0.4× 35 0.9× 28 1.1× 6 175
Jozef Hertecant United Arab Emirates 5 62 0.5× 61 0.9× 20 0.4× 22 0.6× 36 1.4× 7 120
Cynthia A. Cameron United States 6 101 0.7× 68 1.0× 20 0.4× 20 0.5× 25 1.0× 7 145
Detlef Knoll New Zealand 7 80 0.6× 66 1.0× 27 0.5× 29 0.8× 19 0.8× 11 119
Cynthia LeMons United States 5 71 0.5× 43 0.7× 15 0.3× 33 0.9× 25 1.0× 5 117
Friedrich Bosch Germany 3 98 0.7× 68 1.0× 15 0.3× 36 0.9× 15 0.6× 3 126
Ann Wessel United States 11 274 2.0× 119 1.8× 78 1.4× 56 1.5× 32 1.3× 18 309
Cynthia Le Mons United States 5 217 1.6× 131 2.0× 28 0.5× 78 2.1× 36 1.4× 9 270

Countries citing papers authored by Femke Molema

Since Specialization
Citations

This map shows the geographic impact of Femke Molema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Femke Molema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Femke Molema more than expected).

Fields of papers citing papers by Femke Molema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Femke Molema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Femke Molema. The network helps show where Femke Molema may publish in the future.

Co-authorship network of co-authors of Femke Molema

This figure shows the co-authorship network connecting the top 25 collaborators of Femke Molema. A scholar is included among the top collaborators of Femke Molema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Femke Molema. Femke Molema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Molema, Femke, Hanneke A. Haijes, Mirian C. H. Janssen, et al.. (2020). High protein prescription in methylmalonic and propionic acidemia patients and its negative association with long-term outcome. Clinical Nutrition. 40(5). 3622–3630. 9 indexed citations
2.
Molema, Femke, Monique Williams, Jessica Schmiesing, et al.. (2020). Organic acidurias: Major gaps, new challenges, and a yet unfulfilled promise. Journal of Inherited Metabolic Disease. 44(1). 9–21. 29 indexed citations
4.
Molema, Femke, Diego Martinelli, Friederike Hörster, et al.. (2020). Liver and/or kidney transplantation in amino and organic acid‐related inborn errors of metabolism: An overview on European data. Journal of Inherited Metabolic Disease. 44(3). 593–605. 39 indexed citations
5.
Molema, Femke, Florian Gleich, Peter Burgard, et al.. (2019). Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea‐cycle disorders: On the basis of information from a European multicenter registry. Journal of Inherited Metabolic Disease. 42(6). 1162–1175. 26 indexed citations
6.
Haijes, Hanneke A., Femke Molema, Mirjam Langeveld, et al.. (2019). Retrospective evaluation of the Dutch pre‐newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: What to aim, expect, and evaluate from newborn screening?. Journal of Inherited Metabolic Disease. 43(3). 424–437. 20 indexed citations
7.
Molema, Femke, et al.. (2018). Fibroblast growth factor 21 as a biomarker for long‐term complications in organic acidemias. Journal of Inherited Metabolic Disease. 41(6). 1179–1187. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026